Alphyn Biologics has dosed the first patients in a Phase 2 trial of Zabalafin Hydrogel for Molluscum Contagiosum, enrolling 54 patients ages 6 months and older in a placebo-controlled study targeting 75% lesion elimination.
The FDA approved Zycubo (copper histidinate) on January 13, 2026, as the first treatment for Menkes disease in pediatric patients, following resolution of manufacturing compliance concerns that led to an initial rejection in September 2025.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07285785 |
Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea |
RECRUITING | PHASE4 |
| NCT07122596 |
EFFICACY OF PROLONGED INFUSION MEROPENEM IN CRITICALLY ILL PAEDIATRIC INTENSIVE CARE PATIENTS |
COMPLETED | PHASE4 |
| NCT06709521 |
Optimization of Beta-lactam Dosing in Critically Ill Patients With Cystatin C (OPTIMIZE-GNI) |
RECRUITING | PHASE4 |
| NCT05645757 |
Safety Study of Intravenous Ertapenem in Combination With Zidebactam (WCK 6777) |
COMPLETED | PHASE1 |
| NCT05590728 |
Safety of Intravenous Apramycin in Adults |
COMPLETED | PHASE1 |
| NCT04550767 |
: Bacterial Infections in Injecting Drug Users |
COMPLETED | |
| NCT04479657 |
Qingfei Granule for the Treatment of the Pediatric Acute Upper Respiratory Tract Infection With Bacterial Infection |
UNKNOWN | EARLY_PHASE1 |
| NCT03978091 |
A Trial to Evaluate the Pharmacokinetics and Safety of AVYCAZ(R) in Combination With Aztreonam |
COMPLETED | PHASE1/PHASE2 |
| NCT03910673 |
Intravenous Fosfomycin Pharmacokinetics Study |
COMPLETED | PHASE1 |
| NCT03369951 |
Minocycline Pharmacokinetics (ACUMIN) |
COMPLETED | PHASE4 |
